BPG is committed to discovery and dissemination of knowledge
Review
Copyright: ©Author(s) 2026.
World J Clin Pediatr. Jun 9, 2026; 15(2): 117843
Published online Jun 9, 2026. doi: 10.5409/wjcp.v15.i2.117843
Table 8 Clinical Recommendations for screening and monitoring in gut-brain axis-related disorders
Domain of assessment
Rationale for screening
Relevant population
Key clinical outcome measures
Cognitive functionTo identify deficits in processing speed, memory, and attention linked to systemic inflammation and micronutrient deficiencies (e.g., in IBD, CD)NEC survivors, chronic IBD (adolescents/adults), CDintelligence quotient tests (Wechsler Preschool and Primary Scale of Intelligence/Wechsler Intelligence Scale for Children), Reaction Time tests, Verbal/Visual Memory tests
Executive functionTo detect impairments in planning, attention, and cognitive flexibility, commonly seen in active IBD and linked to frontal lobe dysfunctionPediatric IBD (active disease), NEC survivors (attention deficits)Trail Making Test, Stroop Color-Word Test, tests for perseverative errors (California Verbal Learning Test)
Mood/affective statusTo address the high comorbidity of anxiety and depression in IBD and CD, which often mediates poor health-related quality of lifeAll chronic gastrointestinal patients (pediatric and adult)Beck depression inventory, state-trait anxiety inventory, generalized anxiety disorder scale
Inflammatory markersTo correlate inflammation with cognitive status and assess the therapeutic target (i.e., deep healing)IBD and CD patientsPlasma interleukin-6, fecal calprotectin, kynurenine-to-tryptophan ratio


Write to the Help Desk